JULIA DYREYES: Open Payments
NPI 1649939240 · ANNVILLE, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$899 in 35 payments from 9 companies in 2025. Trend: 2023 $0 · 2024 $807 · 2025 $899
Food & beverage: $899
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 16 | $315 |
| Ardelyx, Inc. | 3 | $187 |
| Madrigal Pharmaceuticals | 5 | $149 |
| Janssen Biotech, Inc. | 3 | $90 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 3 | $62 |
| GENZYME CORPORATION | 2 | $47 |
| Regeneron Healthcare Solutions, Inc. | 1 | $18 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $17 |
| Phathom Pharmaceuticals, Inc. | 1 | $14 |
Products named: IBSRELA, MAVYRET, REZDIFFRA, RINVOQ, TREMFYA, DUPIXENT, XIFAXAN, LINZESS.
Industry payments across PA — which companies pay providers there.
